Navigation Links
Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/17/2011

hydrochloride) 43

4.2.4 Serotonin-Norepinephrine Reuptake Inhibitors (SNRI) 44

4.2.5 Cymbalta (duloxetine hydrochloride) 44

4.2.6 Pristiq (desvenlafaxine succinate) 45

4.2.7 Symbyax (olanzapine and fluoxetine combination) 46

4.3 Key Takeaway 48

5 Depression Therapeutics - Pipeline Assessment 49

5.1 Overview 49

5.2 Strategic Pipeline Assessment 49

5.3 Depression Therapeutics Pipeline – Pipeline by Phases of Development 49

5.3.1 Depression Therapeutics – Phase III Pipeline 50

5.3.2 Depression Therapeutics – Phase II Pipeline 50

5.3.3 Depression Therapeutics – Phase I Pipeline 51

5.3.4 Depression Market – Pre-Clinical Pipeline 52

5.3.5 Technology Trends Analytic Framework 52

5.4 Depression Therapeutics Market –Pipeline by Mechanism of Action 56

5.5 Depression Therapeutics – Promising Drugs under Clinical Development 57

5.6 Molecule Profile for Promising Drugs Under Clinical Development 57

5.6.1 Lu AA21004 57

5.6.2 TC-5214 58

5.6.3 AGO178 (agomelatine) 59

5.7 Key Takeaway 60

6 Depression Therapeutics - Clinical Trials Mapping 61

6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 61

6.2 Clinical Trials by Phase 62

6.3 Clinical Trials by Trial Status 63

6.4 Prominent Sponsors 64

6.5 Top Companies Participating in Depression Therapeutics Clinical Trials 66

7 Strategic Assessment 67

7.1 Key Events Impacting the Future Market 67

7.2 Depression Therapeutics: Implications for Future Market Competition 68

8 Depression Therapeutics: Future Players 69

8.1 Introduction 69

8.2 Company Profiles 69

8.2.1 Lundbeck A/S 69

8.2.2 Novartis AG 71

8.2.3 AstraZeneca PLC 72

8.2.4 Eli Lilly and Company 74

8.2.5 Targacept Inc. 75

9 Depression Therapeutics - Licensing and Partner
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Phreesias Digital Depression Screening Improves Early Detection and Drives Better Healthcare Outcomes in Medical Practices
2. Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brain™
3. Reportlinker Adds Product Profiles: Depression - Next generation Vies for Second-Line Patients
4. Naurex Initiates Phase II Clinical Trial of Novel Antidepressant GLYX-13 in Treatment-Resistant Depression
5. Neuralstem Updates NSI-189 Major Depression Trial
6. Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression
7. CeNeRx Initiates Phase II Trial of TriRima™ as Monotherapy in Treatment Resistant Depression
8. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
9. Omega-3 Supplements Show Promise in Alleviating Depression
10. The Welcome Back Awards Seeks Nominations to Honor Leaders in the Depression Community
11. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 Nanomix Inc., (Nanomix), a ... of mobile diagnostic tests to enable earlier ... pre-hospital settings, today announced it has received ... certification was awarded by the British Standards ... certification bodies. ISO 13485:2003 ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen ... AZN ) today announced that AMAGINE-2 TM , a pivotal, ... more than 1,800 patients with moderate-to-severe plaque psoriasis, met its ... and placebo at week 12. Brodalumab 210 mg given every ... shown to be superior to Stelara on the primary endpoint ...
(Date:11/26/2014)... Nov. 26, 2014 China Nepstar Chain Drugstore ... a leading retail drugstore chain in China based on ... unaudited financial results for the third quarter ended September 30, ... 2014: , Same store sales increased by 8.1% ... Revenue increased by 8.1% to RMB738.3 million (US$120.3 million) compared ...
Breaking Medicine Technology:Nanomix Receives ISO 13485:2003 Certification 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11
(Date:11/26/2014)... (PRWEB) November 26, 2014 Increasing ... which include image guided surgeries has paved way ... injectors. Rising incidence of various types of cancers ... proportionate increase in demand for these owing to ... of contrast media injectors market can also be ...
(Date:11/26/2014)... 26, 2014 The city of San ... is moving forward with a plan to recycle wastewater ... host Sharon Kleyne supports the San Diego plan as ... (TWM). According to Kleyne, by recycling water that San ... water could be greatly reduced. (Spagat, E, “San Diego ...
(Date:11/26/2014)... GI for Life announced today, that ... prices of their popular nutritional supplements: ColoVite Colon ... Discounts of 40% will be offered for a ... proprietary ColoVite supplement is a scientifically formulated vitamin supplement ... One easy-to-take colon vitamin with ALL the nutrients associated ...
(Date:11/26/2014)... Call 866-997-4948 (Us-Canada Toll Free) Tel: ... details on sales(at)researchmoz(dot)us , Researchmoz.us announces a new ... 2014" with deep study of the report on the ... blood sugar. The global glucose monitoring market has a ... number of diabetics in the world. Their numbers have ...
(Date:11/26/2014)... 26, 2014 News Facts , ... capabilities at RSNA 2014 in Chicago. The company ... share diagnostic images, photos, videos and documents found ... #8107 will learn more about these innovative medical ... and partner initiatives – that enable more informed ...
Breaking Medicine News(10 mins):Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3
... about 1000 patients were infected with hepatitis B infections. An ... they attended two different// regional hospitals, Waterford Regional Hospital (WRH) ... common among these victims were that they attended the hospital ... aware of their diagnosis. The diagnosis was first made by ...
... beverages, yoga exponent Ramdev today asked the Centre to ... a statutory warning be written on every bottle about ... statutory warning should be written on every bottle that ... and diabetes,' he told reporters here., ,He said ...
... Kandaghat has not been functioning for over a month because of ... official for drug analyzing retired a month ago, the state government ... number of samples awaiting testing at the laboratory has mounted to ... April 30 after 38 years of service. With no one to ...
... Mr S C Jamir, the Governor of Goa, has suggested ... comm maceutical companies should on man. // He made ... a pharmaceutical company, Pliva, at Corlim, Goa,two days ago. ,He ... affordable only by the affluent and it was, therefore, essential ...
... medical colleges should give provisional admissions in reserved quotas ... applying for the same. // ,A candidate, ... days of the admission, the court held., ,For ... provide a caste certificate and a caste-validity certificate (CVC)., ...
... Students in South Australia could be receiving food supplements to ... the go-ahead. Currently, it is still investigating the feasibility of ... South Australian Health Department would review the British study, which ... a daily dose of Omega 3 fish oil. ...
Cached Medicine News:Health News:Working of Drug Department on Hold Without Drug Analyst 2
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: